The mRNA Monthly—August 2024 Newsletter


Rapid Single Epitope mRNA Production

This article presents a synthetic DNA template (SDT) process for manufacturing single epitope mRNA, offering a flexible, cost-efficient, and rapid alternative to traditional plasmid DNA templates (PDT). Read the article to explore what can be instrumental in developing personalized cancer vaccines. 

EXPLORE NOW
Free Online Course: mRNA as Medicines

This new, seven-hour course is meant for anyone interested in understanding how mRNA medicines work, regardless of your current scientific literacy. Equipped with three learning modules, it’s a flexible offering you can schedule and complete on your own time. Melissa J. Moore and Amy Vanko collaborated to develop the learning material and received funding from Moderna for this project.

ACCESS THE COURSE
The Potential of mRNA

This article details an approach to mRNA vaccine manufacturing using microfluidic devices. This method could streamline the development of personalized mRNA vaccines by enabling rapid, scalable, and precise formulation of lipid nanoparticles (LNPs). 

READ MORE
Outsourcing mRNA Production

Pharmaceutical Technology® Group’s Chris Spivey spoke with Vernal’s CEO and founder, Christian Cobaugh about the outsourcing landscape for messenger RNA (mRNA) production in this article and interview. Read more to learn how you can address challenges like growing demand and complexity, enhancing flexibility, speed, and scalability in developing mRNA therapies.

ACCESS THE FULL ARTICLE
16th Annual Bioprocessing Summit

We missed you at the Bioprocessing Summit. Our team member, Sourav Mukherjee is excited to talk to others looking for solutions to their gene therapy products. Reach out to him directly via LinkedIn or book a time to meet via his calendar.

SCHEDULE A MEETING

Subscribe today